Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 Injection (EchoGen®): Its efficacy and side effects

Journal of the American Society of Echocardiography

Volumn 10, Issue 1, 1997, Pages 11-24

  Beppu, Shintaro ^a   Matsuda, Hisao ^a   Shishido, Toshiaki ^a   Matsumura, Manabu ^a   Miyatake, Kunio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUOROPENTANE;

ANIMAL; ARTICLE; BLOOD PRESSURE; DOG; DRUG EFFECT; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE; INTRAVENOUS DRUG ADMINISTRATION; MESENTERIC ARTERY; RAT; TIME; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; CONTRAST MEDIA; DOGS; ECHOCARDIOGRAPHY; FLUOROCARBONS; HEART RATE; HEART VENTRICLES; INJECTIONS, INTRAVENOUS; MESENTERIC ARTERIES; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0030641042     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-7317(97)80028-4     Document Type: Article

References (46)

1. Sakamaki T, Tei C, Meerbaum S, et al. Verification of myocardial contrast two-dimensional echocardiographic assessment of perfusion defects in ischemic myocardium. J Am Coll Cardiol 1984;3:34-8.
2. Kaul S, Pandian NG, Okada RD, Pohost GM, Weyman AE, Lutrario D. Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk." J Am Coll Cardiol 1984;4:1272-82.
3. Kaul S, Glasheen W, Ruddy TD, Pandian NG, Weyman AE, Okada RD. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. Circulation 1987;75:1249-60.
4. Feinstein SB, Lang RM, Dick C, et al. Contrast echocardiography during coronary arteriography in humans: Perfusion and anatomic studies. J Am Coll Cardiol 1988;11:59-65.
5. Cheirif J, Zoghbi WA, Raizner AE, et al. Assessment of myocardial perfusion in humans by contrast echocardiography: I. Evaluation of regional coronary reserve by peak contrast intensity. J Am Coll Cardiol 1988;11:735-43.
6. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
7. Kaul S, Jayaweera AR. Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserve. J Am Coll Cardiol 1993;21:356-8.
8. Agati L, Voci P, Bilotta F, et al. Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiograohic study. J Am Coll Cardiol 1994;24:336-42.
9. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock JJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new in sights using myocardial contrast echocardiography. Circulation 1994;89:2562-9.
10. Feinstein SB, Cheirif J, Ten Cate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990;16:316-24.
11. Von Bibra H, Becher H, Firschke C, Schlief R, Emslander HP, Schomig A. Enhancement of mitral regurgitation and normal left atrial color Doppler flow signals with peripheral venous injection of a saccharide-based contrast agent. J Am Coll Cardiol 1993;22:521-8.
12. Machii K, Sakamoto T, Yoshikawa J, et al. Committee report on a new contrast agent, S 132 (Albunex). J Cardiol 1992;22(suppl.32):13-65.
13. Sanders WEJ, Cheirif BJ, Desir R, et al. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres. Am Heart J 1991;122:1660-5.
14. Voci P, Bilotta F, Merialdo P, Eng C, Agati L. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study. J Am Soc Echocardiogr 1994;7:337-46.
15. Villanueva FS, Glasheen WP, Sklenar I, Jayaweera AR, Kaul S. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast. Circulation 1992;85:1557-64.
16. Beppu S, Matsuda H, Shishido T, Miyatake K. Success of myocardial contrast echocardiography by peripheral venous injection method: visualization of area at risk [abstract]. Circulation 1993;88:1-401.
17. DeMana AN, Dittrich H, Kwan OL, Kimura B. Myocardial opacification produced by peripheral venous injection of a new ultrasonic contrast agent [abstract]. Circulation 1993;88:1-401.
18. Kenny A, Sahn DJ, Shiota T, Passafini A, Pantely G, Arai A. A new phase shift echo contrast agent: Echogen (Sonus Pharmaceuticals) becomes a gas in blood to produce left heart and quantifiable myocardial contrast after venous injection. Studies in sheep and monkeys [abstract]. J Am Coll Cardiol 1994;23:450A.
19. Mor-Avi V, Shroff SG, Robinson K, Ng A, Lang RM. Effects of FS069 new contrast agent on left ventricular contractility: load and rate independent analysis using an isolated rabbit heart [abstract]. Circulation 1994;90:1-68.
20. Grauer S, Pantely GA, Xu JP, ct al. Aerosomes(R) MRX-115: echocardiographic and hemodynamic characteristics of a new echo contrast agent that produces myocardial opacification after intravenous injection in pigs [abstract]. Circulation 1994;90:1-556.
21. Cotter B, Kriett J, Perricone T, et al. Detection of coronary artery occlusion by decreased myocardial opacification follow ing intravenous injection of QW3600 (EchoGen) [abstract]. Circulation 1994;90:1-67.
22. Porter TR, Xie F, Kricsfeld A, Kilzer K. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane ex posed sonicated dextrose albumin. J Am Coll Cardiol 1995;26:33-40.
23. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 1995;26:1340-7.
24. Quay SC. Ultrasound contrast agent development: phase shift colloids. J Ultrasound Med 1994;13:S9. Abstract.
25. Quay SC. Microbubble-based ultrasound contrast agents: the role of gas selection in microbubble persistence [abstract]. J Ultrasound Med 1994;13:S9.
26. Rah KH, Dunwiddie WC, Lower RR. A method for continuous postoperative measurement of mixed venous oxygen saturation in infants and children after open heart procedures. Anesth Analg 1984;63:873-81.
27. Rovai D, Nissen SE, Elion J, et al. Contrast echo washout curves from the left ventricle: application of basic principles of indicator-dilution theory and calculation of ejection fraction. J Am Coll Cardiol 1987;10:125-34.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
29. Kemper AJ, O'Boyle JE, Sharma S, et al. Hydrogen peroxide contrast-enhanced two-dimensional echocardiography: real-time in vivo delineation of regional myocardial perfusion. Circulation 1983;68:603-11.
30. Nanto S, Masuyama T, Lim YJ, Hori M, Kodama K, Kamada T. Demonstration of functional border zone with myocardial contrast echocardiography in human hearts: simultaneous analysis of myocardial perfusion and wall motion abnormalities. Circulation 1993;88:447-53.
31. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation 1993;88:596-604.
32. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol 1984;4:595-600.
33. Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989;65:458-67.
34. Klein AL, Bailey AS, Moura A, et al. Reliability of echocardiographic measurements of myocardial perfusion using commercially produced sonicated serum albumin (Albunex). J Am Coll Cardiol 1993;22:1983-93.
35. Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography comparison with radiolabeled red blood cells. Circ Res 1994;74:1157-65.
36. Keller MW, Glasheen W, Teja K, Gear A, Kaul S. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion. J Am Coll Cardiol 1988;12:1039-47.
37. Shapiro JR, Xie F, Meltzer RS. Myocardial contrast two-dimensional echocardiography: dose-myocardial effect relations of intracoronary microbubbles. J Am Coll Cardiol 1988;12:765-71.
38. Wible JHJ, Wojdyla JK, Baless GL, McMullen WN, Geiser EA, Buss DD. Effects of inspired gas on the efficacy of Albunex in dogs. Circulation 1993;88(suppl I):401. Abstract.
39. Armstrong WF, Mueller TM, Kinney EL, Tickner EG, Dillon JC, Feigenbaum H. Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography. Circulation 1982;66:166-73.
40. Gillam LD, Kaul S, Fallon JT, et al. Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain and kidney. J Am Coll Cardiol 1985;6:687-94.
41. Lang RM, Borow KM, Neumann A, Feinstein SB. Echocardiographic contrast agents: effect of microbubbles and carrier solutions on left ventricular contractility. J Am Coll Cardiol 1987;9:910-19.
42. Ge S, Giraud GG, Shiota T, et al. Microcirculatory flow dynamics during peripheral intravenous injection of Echogen: Microscopic visualization of mesenteric microcirculatory flow with simultaneous transthoracic echo imaging in cats [abstract]. J Am Coll Cardiol 1995;25:227A.
43. Porter T, Xie F, Kricsfeld A. Intravenous dextrose albumin sonicated with evaporated perfluoropentane reduces left ventricular cavity attenuation and improves the echocardiographic detection of posterior myocardial perfusion abnormalities [abstract]. J Am Coll Cardiol 1995;25:204A.
44. Kwan OL, Cotter B, Cha Y, Nozaki S, Calisi C, DeMaria AN. Adjunctive techniques enable myocardial opacification by intravenous injection of reduced doses of QW3600 (EchoGen) [abstract]. J Am Coll Cardiol 1995;25:203A.
45. Cotter B, Keramati S, Kwan OL, Calisi C, Donaghey L, DeMaria AN. Myocardial opacification with low dose activated Echogen in patients: initial experience [abstract]. Circulation 1995;92:I-192.
46. Cotter B, Duong A, Raisinghani A, et al. Myocardial opacification by low doses Echogen in patients: assessment ofpreactivation by closed syringe suction [abstract]. J Am Coll Cardiol 1996;27:126A.